ISSN 1662-4009 (online)

ey0019.4-1 | Important for clinical practice | ESPEYB19

4.1. Recombinant growth hormone therapy for X-linked hypophosphatemia in children

S Smith , T Remmington

Cochrane Database Syst Rev, 2021. 10: p. CD004447 PMID: 34618915Brief Summary: This systematic review examined the effects of rhGH treatment in children with X-linked hypophosphatemia. Despite a significant improvement in height SDS from baseline, evidence from the 2 identified studies was limited to support its clinical use in these patients.X-linked hypophosphatemia (XLH) is an inherited disorder of phosphate homeostasis...